Effectiveness of medications used to treat Helicobacter pylori infection on quality of life in chronic idiopathic urticaria patients

Study of the effect of medications used to treat Helicobacter pylori infection on quality of life in chronic idiopathic urticaria

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016082114333N56

Enrollment

Registered

2016-08-27

Start date

2016-09-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic urticaria. Utricaria

Interventions

Intervention 1: Intervention group addition to the routine treatment of chronic urticaria,will received drug treatment OMC (Omeprazole, Metronidazole, Clarithromycin) for Helicobacter pylori infection

Treatment - Drugs

Placebo

Intervention group addition to the routine treatment of chronic urticaria,will received drug treatment OMC (Omeprazole, Metronidazole, Clarithromycin) for Helicobacter pylori infection for 2 weeks.

The control group will receive usual treatment of chronic urticaria and placebo

Eligibility

Sex/Gender

All

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with chronic urticaria for at least 6 weeks;Normal laboratory data and physical examination to detect the possible causes of chronic urticaria. Exclusion criteria: Pregnant and lactating women; people under 20 and over 40years old; patients with severe Angioedema;Chronic alcoholics and patients with a history of recent use of proton pump inhibitors drugs, antibiotics and bismuth or non steroidal anti-inflammatory drugs or ACE

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Quality of life. Timepoint: Baseline, a month and two months after intervention. Method of measurement: Quality of Life Questionnaire (CU-Q2OL).	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026